We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




World's First Partial Face Transplant

By HospiMedica staff writers
Posted on 13 Dec 2005
French surgeons have carried out the first partial face transplant, using material from a brain-dead donor to rebuild the face of an anonymous 38-year-old woman who lost her nose, lips, and chin when attacked by her pet Labrador.

A surgical team led by Professor Bernard Devauchelle, of Amiens University Hospital (France), and Professor Jean-Michel Dubernard, of Edouard-Herriot Hospital in Lyon (France), carried out the five-hour operation in Amiens in early December 2005. More...
No bones were transplanted during the operation, which involved the use of muscles, cartilage, skin, arteries, veins and nerves to create a "hybrid” face, so that the patient would not completely resemble the donor.

The patient has reportedly been transferred to a hospital in Lyon for a period of four to six weeks, where she will receive further intensive treatment. Doctors said she was starting to stretch and exercise the muscles of her new face, was able to talk coherently, and was beginning to eat and drink without assistance.

The woman had an infusion of bone marrow stem cells from the donor in a second operation several days later and is scheduled to have a second such procedure. The doctors hope that the marrow transplant, an experimental procedure, will help the patient's immune system adapt to her new face and lower the chances of her body rejecting it.

The patient will be put on a protocol including immuno-suppressant and anti-rejection drugs that she will have to continue taking for life and that carry considerable long-term health risks. Among these risks is the chance that the graft will be rejected, leaving the patient in a worse condition than before the operation, the development of cancer from the immunity suppressing drugs given to prevent organ rejection, and the chance that the patient will suffer major psychologic problems in adjusting to a new appearance.

Professor Dubernard led teams that performed a hand transplant in 1998 and the world's first double forearm transplant in 2000. At the press conference on December 2, 2005, team members denied rushing into the facial operation in order to claim a medical first.

In September 2005, Dr. Maria Siemionow, director of plastic surgery at the Cleveland Clinic (OH, USA), noted that she wanted to be the first surgeon in the world to complete a face transplant. "I hope nobody will be frivolous or do things just for fame. We are almost over-cautious,” she said at the time. The clinic declined to comment on the French case.




Related Links:
Amiens University Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.